The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The function of the protein tyrosine phosphatase SHP-1 in cancer
Abstract
SHP-1, an SH2 domain-containing protein tyrosine phosphatase, is primarily expressed in hematopoietic cells and behaves as a key regulator controlling intracellular phosphotyrosine levels in lymphocytes. SHP-1 has been proposed as a candidate tumor suppressor gene in lymphoma, leukemia and other cancers, as it functions as an antagonist to the growth-promoting and oncogenic potentials of tyrosine kinase. The decreased levels of SHP-1 protein and SHP-1 mRNA observed in various leukemia and lymphoma cell lines have been attributed to either the methylation of the promoter region of the SHP-1 gene or the post-transcriptional block of SHP-1 protein synthesis. In contrast, SHP-1 protein is normally or over-expressed in some non-lymphocytic cell lines, such as prostate cancer, ovarian cancer and breast cancer cell lines. SHP-1 expression also is decreased in some breast cancer cell lines with negative expression of estrogen receptor as well as some prostate and colorectal cancer cell lines. These data suggest that SHP-1 can play either negative or positive roles in regulating signal transduction pathways. Dysfunction in SHP-1 regulation can cause abnormal cell growth and induce different kinds of cancers. In this paper, we summarize recent studies on the expression and regulation of SHP-1 protein and its pathological function in the development of lymphoma, leukemia and other cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas the distal promoter, P1, located upstream of the very short exon 1 (sometimes designated also exon 1a) is active in epithelial cells, the proximal promoter P2 that initiates gene transcription from exon 2 (alternatively known as exon 1b), is utilized by the hematopoietic cells.”
From PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells (2007) · cites this paper as [5]
In the citing paper
“Whereas the distal promoter, P1, located upstream of the very short exon 1 (sometimes designated also exon 1a) is active in epithelial cells, the proximal promoter P2 that initiates gene transcription from exon 2 (alternatively known as exon 1b), is utilized by the hematopoietic cells.”
From PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells (2007) · cites this paper as [5]
In the citing paper
“SHP-1 is expressed in the hematopietic and epithelial cells as two structurally similar mRNA transcripts controlled by two different promoters designated P2 and P1, respectively.”
From PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells (2007) · cites this paper as [5]
In the citing paper
“SHP-1 acts mainly by negatively regulating cell signaling by a large spectrum of receptorts for cytokines, growth factors, chemokines, and antigenic and programmed cell death stimuli (1–7”
From PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells (2007) · cites this paper as [5]
In the citing paper
“Whereas the distal promoter, P1, located upstream of the very short exon 1 (sometimes designated also exon 1a) is active in epithelial cells, the proximal promoter P2 that initiates gene transcription from exon 2 (alternatively known as exon 1b), is utilized by the hematopoietic cells.”
From PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells (2007) · cites this paper as [5]
Citations
Cites
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Klingmüller, U., Lorenz, U., Cantley, L. C., Neel, B. G., & Lodish, H. F. (1995) · Cell · doi:10.1016/0092-8674(95)90351-8 · Cited by 929
Shultz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, R. J., Thomas, M. L., & Beier, D. R. (1993) · Cell · doi:10.1016/0092-8674(93)90369-2 · Cited by 581
Activation of a Phosphotyrosine Phosphatase by Tyrosine Phosphorylation
Vogel, W., Lammers, R., Huang, J., & Ullrich, A. (1993) · Science · doi:10.1126/science.7681217 · Cited by 549
Walton, K. M., & Dixon, J. E. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.000533 · Cited by 537
From Form to Function: Signaling by Protein Tyrosine Phosphatases
Tonks, N. K., & Neel, B. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81357-4 · Cited by 531
Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
Wo Tsui, H., Siminovitch, K. A., de Souza, L., & Tsui, F. W. L. (1993) · Nature Genetics · doi:10.1038/ng0693-124 · Cited by 441
Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.
de la Chapelle, A., Träskelin, A. L., & Juvonen, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4495 · Cited by 407
T cell antigen receptor signal transduction
Qian, D., & Weiss, A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80064-6 · Cited by 380
David, M., Chen, H. E., Goelz, S., Larner, A. C., & Neel, B. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.7050 · Cited by 342
Cited by
Inhibitors of Protein Tyrosine Phosphatases: Next‐Generation Drugs?
Bialy, L., & Waldmann, H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461517 · Cited by 420
Albrengues, J., Bertero, T., Grasset, E., Bonan, S., Maiel, M., Bourget, I., Philippe, C., Herraiz Serrano, C., Benamar, S., Croce, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms10204 · Cited by 367
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells
Wlodarski, P., Zhang, Q., Liu, X., Kasprzycka, M., Marzec, M., & Wasik, M. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607526200 · Cited by 29
Metadata
- Authors
- Wu, C.
- Venue
- Gene
- Publisher
- Elsevier BV
- Published
- 2003-03-13
- Volume
- 306
- Pages
- 1-12
- ISSN
- 0378-1119
- Cited by
- 225
- References
- 60
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The function of the protein tyrosine phosphatase SHP-1 in cancer. https://app.cochat.ai/papers/10.1016/s0378-1119(03)00400-1
- The paper
- Wu, C. (2003). The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene. https://doi.org/10.1016/s0378-1119(03)00400-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.